PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies
Molecules · 2023
DOI: 10.3390/molecules28104014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Nuwayo Ishimwe Sincere und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine Center, Lanzhou University Second Hospital, The Second Clinical Medical College of Lanzhou University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Medicine. Die Arbeit wurde bisher 107-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D project of Gansu Provincial Department of science and technology "Development of proteomic Detection and Diagnosis Prediction Model for Gout Based on M…, Establishment of molecular diagnostic methods for stroke susceptibility genes and study of molecular epidemic disease, Key R&D project of Gansu Provincial Department of science and technology “Development of proteomic Detection and Diagnosis Prediction Model for Gout Based….
Abstract (Originalsprache)
A potential therapeutic strategy to treat conditions brought on by the aberrant production of a disease-causing protein is emerging for targeted protein breakdown using the PROTACs technology. Few medications now in use are tiny, component-based and utilize occupancy-driven pharmacology (MOA), which inhibits protein function for a short period of time to temporarily alter it. By utilizing an event-driven MOA, the proteolysis-targeting chimeras (PROTACs) technology introduces a revolutionary tactic. Small-molecule-based heterobifunctional PROTACs hijack the ubiquitin–proteasome system to trigger the degradation of the target protein. The main challenge PROTAC’s development facing now is to find potent, tissue- and cell-specific PROTAC compounds with favorable drug-likeness and standard safety measures. The ways to increase the efficacy and selectivity of PROTACs are the main focus of this review. In this review, we have highlighted the most important discoveries related to the degradation of proteins by PROTACs, new targeted approaches to boost proteolysis’ effectiveness and development, and promising future directions in medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Medicine Center, Lanzhou University Second Hospital, The Second Clinical Medical College of Lanzhou University, Lanzhou 730000, China.
- Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences, University of the Free State, Bloemfontein 9300, South Africa.
- Department of Pharmaceutics, Bharat Institute of Technology (BIT), School of Pharmacy, Meerut 250103, India.
ORCID-Profile: Krishnan Anand, Sumel Ashique
Förderung
- Key R&D project of Gansu Provincial Department of science and technology "Development of proteomic Detection and Diagnosis Prediction Model for Gout Based on M…
- Establishment of molecular diagnostic methods for stroke susceptibility genes and study of molecular epidemic disease
- Key R&D project of Gansu Provincial Department of science and technology “Development of proteomic Detection and Diagnosis Prediction Model for Gout Based…
Zitieren
APA
Sincere, N. I., Anand, K., Ashique, S., Yang, J., & You, C. (2023). PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies. Molecules. https://doi.org/10.3390/molecules28104014
Vancouver
Sincere NI, Anand K, Ashique S, Yang J, You C. PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies. Molecules. 2023. doi:10.3390/molecules28104014
BibTeX
@article{Sincere2023,
author = {Sincere, Nuwayo Ishimwe and Anand, Krishnan and Ashique, Sumel and Yang, Jing and You, Chongge},
title = {PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28104014}
}
EUVIMED